Neurocrine Biosciences (NBIX) Bɛn Dɛŋɛn Akɔc
Bɛ̈ny cɔk aya$138.08Aciic 25 Sep 2026 19:59 UTC
Change-0.62%
AI forecast: NBIX
AI ekek aŋok wɛlɛɛl bɛn bɛn lɔŋɔŋ, bɛn bɛn cɔlɔŋ, kɛ bɛn bɛn cɔlɔŋ. Cɔkɔkɔkɔ cɔlɔŋ bɛn bɛn lɔŋɔŋ. Aŋok wɛlɛɛl aŋok wɛlɛɛl, aŋok wɛlɛɛl aŋok wɛlɛɛl.
Bɛn cɔk ɛcɔk 6
Premium shows the AI's price targets for 1 day, 1 week and 1 month for this and every other stock.
Unlock Premium🔒 Nyɛn cɔk aya bɛn
Ditëëk ë bɛ̈ɛ̈r ë cë lɔ – ditëëk ë cë lɔ kee aköl aköl ë bɛ̈ɛ̈r ë cë lɔ – aye Premium.
Unlock PremiumBɛn kɔc ke bɛn
Neurocrine Biosciences, Inc. (NBIX) researches and develops therapeutic agents for the treatment of psycho-neurological, neuroinflammatory, and neurodegenerative diseases and disorders, as well as for neuroses, depression, Alzheimer’s disease, stroke, malignant brain tumors, multiple sclerosis, obesity, and diabetes.
